Back to discover

Protein / target

Lysosome-associated membrane glycoprotein 3

Encoded byLAMP3Q9UQV4Homo sapiensSwiss-Prot
Antibody-tractable
Druggability
UniProt loc high conf
1
Research papers

Protein at a glance

Biological role

Negative regulation of proteasomal protein catabolic process

Strongest disease association

Alcohol drinking

Via encoding gene LAMP3 · Genetic evidence · score 0.45

Research activity

Emerging research

1 papers · latest 2020

Derived from structured UniProt, Open Targets and literature data on this page.

Protein profile

UniProt 2026_02

Canonical identity and biological annotation from UniProt.

Function overview

Lysosomal membrane glycoprotein which plays a role in the unfolded protein response (UPR) that contributes to protein degradation and cell survival during proteasomal dysfunction.

View complete UniProt function annotation

Lysosomal membrane glycoprotein which plays a role in the unfolded protein response (UPR) that contributes to protein degradation and cell survival during proteasomal dysfunction (PubMed:25681212). Plays a role in the process of fusion of the lysosome with the autophagosome, thereby modulating the autophagic process (PubMed:24434718). Promotes hepatocellular lipogenesis through activation of the PI3K/Akt pathway (PubMed:29056532). May also play a role in dendritic cell function and in adaptive immunity (PubMed:9768752)

Subcellular location

Cell surfaceLysosome membraneCytoplasmic vesicle membraneEarly endosome membrane
Domains and Gene Ontology detail (16)

Gene Ontology

  • Calveolar lamellar body membrane
  • Ccell surface
  • Cearly endosome
  • Cearly endosome membrane
  • Clate endosome membrane
  • Clysosomal membrane
  • Cperinuclear region of cytoplasm
  • Cplasma membrane
  • Cvesicle
  • Padaptive immune response
  • Pestablishment of protein localization to organelle
  • Pnegative regulation of proteasomal protein catabolic process

416 aa · 44 kDa

Biological roles

What this protein does, drawn together from its UniProt function, Gene Ontology terms and Reactome pathways.

Cell proliferation & survivalUniProt
View supporting evidence

Cell proliferation & survival

  • ·Lysosomal membrane glycoprotein which plays a role in the unfolded protein response (UPR…

Concepts derived from UniProt GO Reactome — each badge above shows which sources supported that role.

Translational evidence

Open Targets 26

Why this target matters therapeutically, strongest evidence first. Disease associations are gene-level (via the gene that encodes this protein) and open into the full confidence synthesis; the development universe, tractability and safety annotations are target-level, from Open Targets.

Strongest disease associations · via encoding gene LAMP3

Gene-level evidence surfaced through the gene LAMP3 that encodes this protein — not a direct protein–disease relationship. Ranked by Forefront's causal-directness weighting, so genetically- and clinically-evidenced diseases lead over ones that merely share the literature.

Alcohol drinking
0.45Limited support

Genetic evidence dominant · Open Targets 0.27

Heart Diseases
0.43Limited support

Genetic evidence dominant · Open Targets 0.26

Liver Diseases
0.42Limited support

Genetic evidence dominant · Open Targets 0.26

Parkinson's Disease
0.25Limited support

Genetic evidence dominant · Open Targets 0.14

Neoplasms
0.14Preliminary

Literature evidence dominant · Open Targets 0.11 · no direct causal or clinical evidence

View evidence synthesis (5)
Alcohol drinkingLimited support
0.45
agreement 0.330.57
Genetic100%

Open Targets aggregate 0.27 · 1 independent evidence family

Heart DiseasesLimited support
0.43
agreement 0.310.55
Genetic100%

Open Targets aggregate 0.26 · 1 independent evidence family

Liver DiseasesLimited support
0.42
agreement 0.290.56
Genetic99%Literature1%

Open Targets aggregate 0.26 · 2 independent evidence families

Parkinson's DiseaseLimited support
0.25
agreement 0.110.39
Genetic80%Literature20%

Open Targets aggregate 0.14 · 2 independent evidence families

NeoplasmsPreliminary
0.14
agreement 0.000.41
Literature100%

Open Targets aggregate 0.11 · 1 independent evidence family · no direct causal or clinical evidence

The evidence agreement range shows how closely the independent evidence families agree — it is not a statistical confidence interval, and nothing here is fitted to outcome data. Derived from Open Targets evidence types under Forefront weighting; the per-type scores above show the calculation.

Show all associations
Alcohol drinking0.27
Heart Diseases0.26
Liver Diseases0.26
Parkinson's Disease0.14
Neoplasms0.11
Esophageal Squamous Cell Carcinoma0.08

Tractability

AntibodiesEmerging

Feasibility evidence (uniprot loc high conf and go cc high conf) — no clinical-stage drug of this modality recorded.

View underlying tractability evidence (3)
AB · UniProt loc high confAB · GO CC high confAB · UniProt SigP or TMHMM

Raw Open Targets tractability assessment buckets, by modality.

Research activity

1 papers · to 2020

Papers linked directly to this protein. This is the protein's own literature — descriptor-derived papers are kept separate below.

Most cited

Recent

Europe PMC papers linked directly to this protein.